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Understanding drug–biomembrane interactions at high resolution is a key issue in current biophysical and pharmaceutical research. Here
we used real-time atomic force microscopy (AFM) imaging to visualize the interaction of the antibiotic azithromycin with lipid domains in
model biomembranes. Various supported lipid bilayers were prepared by fusion of unilamellar vesicles on mica and imaged in buffer
solution. Phase-separation was observed in the form of domains made of dipalmitoylphosphatidylcholine (DPPC), sphingomyelin (SM), or
SM/cholesterol (SM/Chl) surrounded by a fluid matrix of dioleoylphosphatidylcholine (DOPC). Time-lapse images collected following
addition of 1 mM azithromycin revealed progressive erosion and disappearance of DPPC gel domains within 60 min. We attribute this effect
to the disruption of the tight molecular packing of the DPPC molecules by the drug, in agreement with earlier biophysical experiments. By
contrast, SM and SM-Chl domains were not modified by azithromycin. We suggest that the higher membrane stability of SM-containing
domains results from stronger intermolecular interactions between SM molecules. This work provides direct evidence that the perturbation of
lipid domains by azithromycin strongly depends on the lipid nature and opens the door for developing new applications in membrane
biophysics and pharmacology.
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1. Introduction biological membranes [6]. Experimental work on artificialDue to their unique properties, supported lipid bilayers are
attracting more and more attention in basic and applied
research. These systems are widely used as models to
investigate the properties of biological membranes and
associated processes such as molecular recognition, enzy-
matic catalysis, cell adhesion and membrane fusion [1–3].
Supported lipid bilayers are also important for a number of
applications, including the design of biosensors, the biofunc-
tionalization of solid surfaces, the crystallization of proteins
and the immobilization of DNA [3–5]. While liposomes
have been extensively used in pharmaceutical research as
drug-delivery systems and assays for studying drug–mem-
brane interactions [6], the potential of supported lipid
bilayers in this area has been largely underestimated so far.
In pharmacology, the biological activity of a number of
drugs is known to directly depend on their interaction with0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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that the membrane properties may strongly be affected by
the presence of membrane associated molecules. Examples
of parameters that can be affected by drug–membrane
interactions include the conformation of acyl groups, the
membrane surface and thickness, the phase transition tem-
perature, the membrane potential and hydration of head
groups and the membrane fusion properties [7]. Evidence is
also increasing that the presence of a heterogeneous lateral
organization may have a number of important consequences
on this interaction, including enhancement of penetration
and insertion of the molecules at the domain boundary [8].
Monte Carlo calculations on model membranes have also
revealed that application of a drug may itself have an
influence on the lateral organization of the lipid membrane
[8]. Accordingly, understanding the interaction of drugs
with lipid membranes has long been a key issue in mem-
brane biophysics and pharmaceutical research.
A number of techniques are available to characterize
membrane domain topology, such as fluorescence micros-
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freeze-etch electron microscopy. Despite this variety of
methods, little was known until recently about the structure
and properties of lipid films at the nanometer level. In this
context, atomic force microscopy (AFM) has recently be-
come an essential tool in lipid film research [9]. The
instrument has been used to characterize the molecular
structure of lipid films in aqueous environment [10,11],
the organization of phase-separated films [12–16], the
surface of crystalline protein arrays anchored to lipid
bilayers [13,17] or reconstituted in the presence of lipids
[18], and the interaction with external agents such as
alcohols [19], peptides [20] and drugs [21,22]. In addition,
the unique real-time imaging capability of AFM has been
used to monitor time-dependent processes such as the
insertion of proteins into model membranes [23–25] and
the growth of single lipid domains in lipid bilayers [15].
In this report, we present the first real-time observation of
the interaction of antibiotics with lipid domains in supported
lipid bilayers using AFM. Mixed dioleoylphosphatidylcho-
line/dipalmitoylphosphatidylcholine (DOPC/DPPC) bilayers
were used because choline phospholipids are commonly
found in eukaryotic cell membranes and this specific mix-
ture is known to separate at room temperature into fluid and
gel phases [15]. DOPC/DPPC bilayers were compared with
bilayers containing sphingomyelin (SM) because these are
known to form domains which can be considered as simple
models of lipid microdomains (rafts) found in natural
biomembranes [26–28]. Supported bilayers were imaged
in real time by AFM, in the absence or presence of the
dicationic antibiotic azithromycin (Fig. 1). We chose azi-
thromycin because this amphiphilic antibiotic is known to
interact with lipid bilayers. Conformational analysis showed
that the drug is capable of interacting both with the
hydrophilic and hydrophobic regions of a lipid monolayerFig. 1. Structural formula of azithromycin.[29]. More recently, equilibrium dialysis and nuclear mag-
netic resonance (NMR) spectroscopy experiments revealed
that this antibiotic is able to bind to phospholipid bilayers
and especially to interact with the phosphate heads [30].
Despite the accumulation of experimental data on azithro-
mycin–membrane interactions, direct information at high
resolution is still lacking.2. Materials and methods
2.1. Materials
DOPC, DPPC, SM and Chl were purchased from Sigma
(St. Louis, MO). Azithromycin (dihydrate free base for
microbiological standard; 94% purity) was generously sup-
plied by Pfizer s.a. (Brussels, Belgium) on behalf of Pfizer
Inc. (Groton, CT, USA). Other chemicals were purchased
from Merck (Darmstadt, Germany). Azithromycin was dis-
solved in 0.1 N HCl and thereafter diluted to the desired
final concentrations. Three different solutions were used for
preparing and imaging the lipid bilayers, i.e. Tris/NaCl/
CaCl2 (10 mM Tris, 100 mM NaCl, 3 mM CaCl2, pH 7.4),
Tris/NaCl (10 mM Tris, 100 mM NaCl, pH 7.4) and Tris/
NaCl/azithromycin (10 mM Tris, 100 mM NaCl, 1 mM
azithromycin, pH 7.4).
2.2. Preparation of lipid bilayers
Supported bilayers were prepared as follows. Lipid
mixtures were dissolved in CHCl3/MeOH 2:1 (v/v) in glass
tubes, evaporated with nitrogen and dried in a desiccator
under vacuum for 2 h. The lipids were then resuspended
from the walls of the glass tube by vigorous vortexing in
Tris/NaCl/CaCl2 buffer (f 5 ml). To obtain small unila-
mellar vesicles (SUVs), the suspension was sonicated to
clarity (five cycles of 2 min) using a 500-W probe sonicator
(Fisher Bioblock Scientific, France; 35% of the maximal
power; 13 mm probe diameter) while keeping the suspen-
sion in an ice bath and the suspension was finally filtered on
0.2-Am nylon filters (Whatman Inc., USA) to eliminate
titanium particles. The SUV solution was then put into
contact with freshly cleaved mica substrates for 45 min at
60 jC. After slowly cooling down the system to room
temperature, the samples were carefully rinsed to remove
the SUV excess using either a Tris/NaCl solution or a Tris/
NaCl/azithromycin solution. Samples were then attached to
a steel sample puck (Digital Instruments, Santa Barbara,
CA) using a small piece of adhesive tape and transferred
into the AFM liquid cell while avoiding dewetting.
2.3. AFM imaging
AFM measurements were made at room temperature
(f 23 jC), using a commercial microscope (Nanoscope
III, Digital Instruments). Contact mode topographic images
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sharpened microfabricated Si3N4 cantilevers (ThermoMicro-
scopes, Sunnyvale, CA) with typical radius of curvature of
20 nm and spring constants of 0.01 and 0.03 N/m (manu-
facturer-specified). The applied force was kept as low as
possible (< 1 nN) and the scan rate was 3–5 Hz. All images
were flattened (flattening order of 1 or 2).3. Results and discussion
With the aim to gain insight into azithromycin–mem-
brane interactions, supported lipid bilayers made of DPPC/
DOPC, SM/DOPC and SM/Chl/DOPC mixtures were pre-
pared by fusion of unilamellar vesicles on mica. Time-lapse
AFM images were recorded in buffer solution, either in the
absence or presence of azithromycin.
3.1. DPPC/DOPC bilayers
Fig. 2A presents a typical topographic image of a mixed
DPPC/DOPC (1:1, mol/mol) bilayer supported on mica
recorded in buffer solution. The bilayer clearly showed
phase-separation in the form of well-defined elevated
domains surrounded by a continuous matrix. In the light
of the known phase diagrams of the lipids and of previous
work [15], the elevated domains may unambiguously be
attributed to DPPC in the gel phase and the matrix to DOPC
in the fluid phase. Consistent with earlier AFM studies
[15,25], we note that the shape of the DPPC domains was
irregular, with a size ranging from 100 to 1500 nm. The step
height measured between the DPPC and DOPC phases was
1.1F 0.05 nm, which is larger than the value expected from
the DPPC and DOPC film thicknesses. This behavior is
likely to result from a difference in the film mechanical
properties [12]. It is also worth noting that only two discrete
topographic levels were observed in all images, suggestingFig. 2. AFM height images (7.5 7.5 Am; z-scale : 10 nm) of a mixed DPPC/DO
immediately after sample mounting. (B) Image obtained after scanning the surfacthat for DPPC/DOPC bilayers prepared by vesicle fusion the
gel domains in the two monolayers are coupled [15].
To assess the stability of DPPC/DOPC bilayers during
consecutive scanning in buffer, successive images of the
same bilayer location were recorded. As can be seen in Fig.
2B, scanning the bilayer surface for 60 min did not cause
any significant change of the surface morphology, indicating
that the bilayer was stable in these conditions.
3.2. DPPC/DOPC bilayers incubated with azithromycin
Supported DPPC/DOPC bilayers were incubated with a 1
mM azithromycin solution and successive AFM images
were then recorded at the same location. A series of
topographic images recorded after 2, 12, 18, 26, 31, 36,
44, 58 and 63 min is shown in Fig. 3. After 2 min of
incubation, the bilayer morphology, i.e. domain geometry
and surface coverage, was similar to that observed in the
absence of azithromycin (Fig. 2A). After 12 min, however,
the smallest DPPC gel domains disappeared, yielding a
topographic level which was similar to that of the DOPC
matrix. Increasing the incubation time led to a progressive
decrease of the size of the DPPC domains and to their
disappearance. After 63 min, gel domains were no longer
visible, the bilayer surface being totally homogeneous. We
note that for all incubation times the bilayer surface was
devoid of defects, i.e. holes in the upper monolayer or in the
bilayer were never observed.
One may argue that the observed morphological changes
are due to consecutive scanning by the AFM tip rather than
to the action of the drug. To test this hypothesis, two control
experiments were carried out. First, at the end of the time-
dependent experiment (Fig. 3), the tip was moved f 1 mm
aside and a topographic image of a new zone was recorded.
The image revealed a totally homogeneous surface mor-
phology that was similar to that observed at the first location
at the end of the time-dependent experiment (63 min).PC (1:1, mol/mol) bilayer in Tris/NaCl buffer. (A) Image recorded almost
e for 60 min.
Fig. 3. AFM height images (7.5 7.5 Am; z-scale : 10 nm) of a mixed DPPC/DOPC (1:1, mol/mol) bilayer recorded in a Tris/NaCl/azithromycin solution at
increasing incubation times.
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a well containing a 1 mM azithromycin solution and
transferred into the AFM fluid cell for subsequent imaging.
Images recorded in different locations did all present a
homogeneous surface morphology. Note that in these two
experiments the presence of a lipid bilayer on the mica
substrate was confirmed using force–distance curves and
scratching experiments (data not shown). Taken together,
these data indicate that the time-dependent erosion of the
DPPC gel domains is due to the action of azithromycin
rather than to a simple scanning artifact.
Several pieces of evidence suggest that the progressive
erosion and disappearance of the DPPC gel domains reflect
a modification of the molecular packing of individual DPPC
molecules resulting from the interaction with the drug. First,
several differential scanning calorimetry (DSC) studies haveshown that cationic amphiphilic drugs are able to lower the
phase-transition temperature of liposomes made of phos-
pholipids, an effect which was related to the penetration and
intercalation of the drug into the lipid bilayer. For instance,
the transition temperature of dipalmitoylphosphatidic acid
(DPPA) liposomes was shown to decrease from 64 to 11 jC
in the presence of cationic amphiphilic drugs [31]. For
DPPC liposomes, Kursch et al. [32] demonstrated that the
transition temperature is depressed by 16 different cationic
compounds; for example, addition of chlorphentermine at a
5:1 ratio (mol drug/mol DPPC) decreased the transition
temperature from 41 to 25 jC. Second, equilibrium dialysis
and NMR experiments showed that azithromycin is able to
bind to phospholipid bilayers at neutral pH by interacting
with the phosphate groups [30]. Third, molecular modeling
studies of azithromycin in interaction with phospholipids
Fig. 4. AFM height images (5 5 Am; z-scale : 10 nm) of a mixed SM/DOPC (1:1, mol/mol) bilayer recorded in Tris/NaCl (A, B) and Tris/NaCl/azithromycin
(C, D) solutions. (A, C) Images recorded almost immediately after sample mounting. (B, D) Images obtained after scanning the surface for 60 min.
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the hydrophilic and hydrophobic domains of a phospholipid
monolayer [29]. Taken together, the above observations lead
us to believe that the time-dependent erosion of the gel-
phase domains observed here is due to the interaction
between individual azithromycin and DPPC molecules.
Presumably, disruption of the interactions between the lipid
polar headgroups, and possibly between the hydrocarbon
chains, due to the intercalation of the drug, is responsible for
the progressive disappearance of the domains. In future
work, it would be interesting to investigate the influence
of azithromycin concentration on the erosion process.
Interestingly, we also note in the set of images of Fig. 3
that the inner region of most gel domains remained essen-
tially homogeneous during the course of the experiment,
indicating that the erosion process proceeds essentially at
the boundary of the gel and fluid phases. The preference of
the drug for the interface is consistent with the expectation
that accessibility of the drug should be enhanced due to the
molecular packing disorder associated with this region [8].
This finding is also in agreement with previous real-time
AFM studies of the interaction of proteins with lipid
membranes. Milhiet et al. [24,25] reported that when
phase-separated SM/DOPC and DPPC/DOPC bilayer sys-tems are incubated with alkaline phosphatase, the proteins
insert preferentially at the gel-fluid phase boundary, a
behavior that was related to a decrease in the interfacial
tension at the phase boundary.
3.3. SM/DOPC and SM/Chl/DOPC bilayers in the absence
and presence of azithromycin
Evidence is growing that natural biomembranes contain
lipid microdomains (rafts) composed of SM, Chl and
glycosphingolipids [26,27]. These structures are thought to
play important roles in processes such as cellular signaling
and membrane trafficking. The raft hypothesis suggests that
the lipids aggregate in the plane of the membrane driven
only by distinct intermolecular forces including van der
Waals interactions and hydrogen bonding. These interac-
tions would explain the detergent resistance of lipid rafts.
SM and Chl are known to preferentially interact and to form
domains in the liquid-ordered phase [24]. In this phase, the
lipid molecules are tightly packed as in the gel phase but the
lateral diffusion is almost as high as in the fluid phase.
This prompted us to compare the behavior of DPPC
domains with that of SM and SM/Chl domains. A topo-
graphic image of a mixed SM/DOPC (1:1, mol/mol) bilayer
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observed, the elevated domains being attributed to SM in
the gel phase and the surrounded matrix to DOPC in the
fluid phase. The domain geometry (shape, size) was found
to be similar to that of the DPPC/DOPC system but the
height difference was somewhat smaller, i.e. 0.85F 0.03
nm. Comparable observations were recently reported by
Milhiet et al. [24]. As shown in Fig. 4B, scanning the
surface repeatedly for 60 min did not change significantly
the domain morphology. Strikingly, Fig. 4C and D reveals
that the morphology of the SM/DOPC bilayer incubated
with azithromycin was not perturbed, even after 60 min.
This indicates that, as opposed to the DPPC behavior, the
organization of SM molecules in the gel phase is not
significantly affected by the drug.
As can be seen in Fig. 5A and B, the morphology of
mixed SM/Chl/DOPC (1:1:1, mol/mol/mol) bilayers was
not too different from that observed in the absence of
cholesterol except that the domain size ranged from 3 to 5
Am. We attribute these large domains to SM/Chl in the
liquid-ordered phase [24,33]. Scanning the surface for 60
min did not alter the domain morphology, a finding which isFig. 5. AFM height images (5 5 Am; z-scale : 10 nm) of a mixed SM/Chl/DOPC
azithromycin (C, D) solutions. (A, C) Images recorded almost immediately after s
min.in contrast with previous AFM studies [24] and with the
notion that cholesterol increases the lipid mobility in liquid-
ordered phases. Further work is needed to assess whether
the nature and composition of the lipid bilayers and buffer
solution used here may account for this discrepancy. An-
other interesting question is whether the SM/Chl domains,
owing to their enhanced lateral diffusion properties, would
be more sensitive to azithromycin compared to SM domains.
Fig. 5C and D reveals that the domain organization was not
altered even after 60 min, indicating that SM/Chl liquid-
ordered domains are resistant to the drug.
At first, the higher membrane stability of SM-containing
domains compared to DPPC domains may be surprising
since both lipids have the same polar headgroups. However,
they are known to differ significantly in the other regions
[28,34]. In the interfacial region of SM, the amide and
hydroxyl groups give the molecule the unique ability to
form intra- and intermolecular hydrogen bonding, a property
that has been speculated to provide a driving force for lipid
raft formation. In comparison, PC through its carbonyl
esters can only accept hydrogens. Furthermore, the trans
double bond between the C-4 and C-5 atoms of the(1:1:1, mol/mol/mol) bilayer recorded in Tris/NaCl (A, B) and Tris/NaCl/
ample mounting. (B, D) Images obtained after scanning the surface for 60
A. Berquand et al. / Biochimica et Biophysica Acta 1664 (2004) 198–205204sphingosine moiety has the ability to induce dipoles in the
interfacial region. Several important consequences may
result from this, including better chain stacking, closer lipid
packing, membrane stabilization and lower membrane per-
meability [34]. We therefore suggest that the higher stability
of SM-containing domains reflects tighter lipid packing
owing to stronger intermolecular interactions between the
lipid molecules.4. Conclusion
We have shown that real-time AFM imaging is a valuable
approach to probe the dynamic interaction of drugs, such as
antibiotics, with lipid domains in model membranes. Incu-
bation of DPPC/DOPC bilayers with azithromycin causes a
time-dependent erosion and disappearance of the DPPC
domains attributed to the disruption of the molecular pack-
ing by the drug. By contrast, SM and SM-Chl domains are
not modified by azithromycin. In agreement with the
literature data, we propose that the higher membrane stabil-
ity observed for SM-containing domains results from stron-
ger intermolecular interactions between SM molecules. Our
results point to the power of real-time AFM imaging for
monitoring the interaction of biologically active molecules
such as drugs and peptides with lipid membranes.Acknowledgements
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